These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 6865850

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The adverse effects of hormonal therapy.
    Bush TL.
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [Abstract] [Full Text] [Related]

  • 26. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Nov; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Oral contraception: disadvantages of estrogen reduction].
    Denis C.
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [Abstract] [Full Text] [Related]

  • 33. Oral contraceptives and lipoprotein metabolism.
    Tikkanen MJ, Nikkilä EA.
    J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
    [Abstract] [Full Text] [Related]

  • 34. Oral contraception: past, present, and future perspectives.
    Mishell DR.
    Int J Fertil; 1991 Sep; 36 Suppl 1():7-18. PubMed ID: 1678381
    [Abstract] [Full Text] [Related]

  • 35. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC.
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Pros and cons of triphasic oral contraception].
    Berdah J.
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [Abstract] [Full Text] [Related]

  • 40. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.